Loading...
Corcept Therapeutics Incorporated
CORT•NASDAQ
Healthcare
Biotechnology
$34.24
$0.00(0.00%)
U.S. Market is Open • 14:02Corcept Therapeutics Incorporated (CORT) AI-Powered Stock Analysis
See how Corcept Therapeutics Incorporated scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerCorcept Therapeutics Incorporated (CORT) Stock Overall Grade
Corcept Therapeutics Incorporated’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Corcept Therapeutics Incorporated's overall stock rating.
Forecast
A+Score
98/100Financial Growth
A+Score
100/100Fundamental Growth
AScore
86/100Key Ratios
AScore
80/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
BScore
63/100Corcept Therapeutics Incorporated (CORT) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 98/100 (A+), reflecting high confidence in its potential. Financial Growth (100/100, A+) and Fundamental Growth (86/100, A) highlight its stability, while Key Ratios (80/100, A) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (63/100,B) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Corcept Therapeutics Incorporated stock grade, including financials, comparisons, and forecasts.